Abstract Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with nearly 1 million new cases diagnosed annually. Despite innovations in diagnosis, most patients still present at advanced stages, contributing to a poor prognosis. For early gastric cancer, endoscopic resection or minimally invas...
ABSTRACT Advanced‐stage gastrointestinal (GI) cancers present an unmet need for innovative therapies, and antibody‐drug conjugates (ADCs) offer promising solutions. This study investigates the antitumor efficacy and toxicity of AMT‐676, a novel ADC targeting Cadherin 17 (CDH17), in GI cancers. Utilizing MabArray screen...
Ying-Nan Wang, Dan-Yun Ruan, Jing Shi et al.· Advancement of science· 0 citations
This review systematically categorizes and synthesizes findings from key EC clinical trials conducted over the past five years and integrates the current understanding of molecular pathogenesis, targeted therapeutic approaches, the tumor immune microenvironment, and emerging treatment strategies.
Ying-Nan Wang, Xiao-Wen Lian, Yu-Kun Chen et al.· Chinese Medical Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
